Revvity (RVTY) EBITDA Margin Growth (1y) (2010 - 2026)
Revvity (RVTY) EBITDA Margin Growth (1y) (2010 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 50.00 |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | 519.00 |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | 136.00 |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 376.00 |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | -101.00 |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | 235.00 |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | 93.00 |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | 352.00 |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | -78.00 |
| 10 | Revvity | 12.76 Bn | 11.90 Bn | 387.66 Mn | -19.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 5, 2026 | -19.00 |
| Dec 28, 2025 | -181.00 |
| Sep 28, 2025 | -263.00 |
| Jun 29, 2025 | 21.00 |
| Mar 30, 2025 | 408.00 |
| Sep 29, 2024 | 403.00 |
| Jun 30, 2024 | 139.00 |
| Mar 31, 2024 | -449.00 |
| Oct 1, 2023 | -524.00 |
| Jul 2, 2023 | -1,495.00 |
| Apr 2, 2023 | -1,592.00 |
| Jan 1, 2023 | -1,063.00 |
| Oct 2, 2022 | -714.00 |
| Jul 3, 2022 | -786.00 |
| Apr 3, 2022 | -1,707.00 |
| Jan 2, 2022 | -849.00 |
| Oct 3, 2021 | -302.00 |
| Jul 4, 2021 | 1,218.00 |
| Apr 4, 2021 | 3,742.00 |
| Jan 3, 2021 | 2,050.00 |